Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on: January 10,2024

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on:January 10,2024

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on: March 29,2024

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on:March 29,2024

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Updated on: January 26,2024

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Updated on:January 26,2024

Social determinants of health affect racial disparity in prostate cancer mortality

by Elana GotkineWhen accounting for social determinants of health (SDOH), Black men with prostate cancer have lower prostate cancer-specific mortality (PCSM) than White men, according to a systematic

Updated on: December 26,2023

Social determinants of health affect racial disparity in prostate cancer mortality

by Elana GotkineWhen accounting for social determinants of health (SDOH), Black men with prostate cancer have lower prostate cancer-specific mortality (PCSM) than White men, according to a systematic

Updated on:December 26,2023

Researchers identify mechanism that allow ketamine to act both fast and slow

by Northwestern UniversityMultiple doses of ketamine do not increase the activity of immature neurons. Credit:Cellular and Molecular Life Sciences(2024). DOI: 10.1007/s00018-024-05121

Updated on: May 16,2024

Researchers identify mechanism that allow ketamine to act both fast and slow

by Northwestern UniversityMultiple doses of ketamine do not increase the activity of immature neurons. Credit:Cellular and Molecular Life Sciences(2024). DOI: 10.1007/s00018-024-05121

Updated on:May 16,2024

Magnetic field patterns found to cause oncolysis via oxidative stress in glioma cells

by Thamarasee Jeewandara , Medical XpressCell culture stimulation setup, stimulation protocol and thermal imaging during sOMF stimulation to measure temperature changes. (A) Left—A schematic diagram o

Updated on: January 04,2024

Magnetic field patterns found to cause oncolysis via oxidative stress in glioma cells

by Thamarasee Jeewandara , Medical XpressCell culture stimulation setup, stimulation protocol and thermal imaging during sOMF stimulation to measure temperature changes. (A) Left—A schematic diagram o

Updated on:January 04,2024

Researchers study the risk of false positives in colon cancer screening

by IDIBELL-Bellvitge Biomedical Research InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer can develop for months without producing any s

Updated on: June 04,2024

Researchers study the risk of false positives in colon cancer screening

by IDIBELL-Bellvitge Biomedical Research InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer can develop for months without producing any s

Updated on:June 04,2024

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance

Updated on: January 30,2024

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance

Updated on:January 30,2024

RNA thought to spread cancer shows ability to suppress breast cancer metastasis

byUniversity of Texas M. D. Anderson Cancer CenterLi Ma, Ph.D. Credit: MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RN

Updated on: December 18,2023

RNA thought to spread cancer shows ability to suppress breast cancer metastasis

byUniversity of Texas M. D. Anderson Cancer CenterLi Ma, Ph.D. Credit: MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RN

Updated on:December 18,2023

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ

Updated on: December 18,2023

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ

Updated on:December 18,2023

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve

Updated on: February 20,2024

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve

Updated on:February 20,2024

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Updated on: January 29,2024

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Updated on:January 29,2024